An open label, randomised, parallel group clinical study to evaluate the effect of the Connected Inhaler System (CIS) on adherence to Relvar/Breo ELLIPTA therapy, in asthmatic subjects with poor control.
Phase of Trial: Phase IV
Latest Information Update: 09 Apr 2018
At a glance
- Drugs Vilanterol/fluticasone furoate (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 09 Apr 2018 Planned End Date changed from 8 Jul 2020 to 8 Jun 2020.
- 23 Mar 2018 New trial record